No data to show
OTCM
IDXAD
Market cap1mUSD
Mar 12, Last price
0.00USD
Name
Idex Biometrics ASA
Chart & Performance
P/E
—
P/S
0.24
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-14.17%
Rev. gr., 5y
75.37%
Revenues
4m
+1.47%
Net income
-27m
L-18.21%
CFO
-28m
L-12.46%
Earnings
Aug 13, 2025
Profile
IDEX Biometrics ASA engages in the design, development, and sale of fingerprint authentication solutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. IDEX Biometrics ASA was incorporated in 1996 and is headquartered in Oslo, Norway.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 4,152 1.47% | 4,092 44.08% | |||||||
Cost of revenue | 7,568 | 28,547 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (3,416) | (24,455) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | (36) | ||||||||
Tax Rate | |||||||||
NOPAT | (3,416) | (24,419) | |||||||
Net income | (26,713) -18.21% | (32,662) 0.34% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 14,899 | 14,936 | |||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 11,432 | 402 | |||||||
Long-term debt | 14,445 | 2,686 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | (11,336) | ||||||||
Net debt | 14,408 | (13,036) | |||||||
| Cash flow | |||||||||
Cash from operating activities | (27,922) | (31,897) | |||||||
CAPEX | (267) | ||||||||
Cash from investing activities | (160) | ||||||||
Cash from financing activities | 23,197 | 14,503 | |||||||
FCF | (282) | (28,493) | |||||||
| Balance | |||||||||
Cash | 11,388 | 16,124 | |||||||
Long term investments | 81 | ||||||||
Excess cash | 11,261 | 15,919 | |||||||
Stockholders' equity | 9,245 | (22,771) | |||||||
Invested Capital | 194 | 47,156 | |||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 253,042 | 13,760 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (1,710) | (23,103) | |||||||
EV/EBITDA | |||||||||
Interest | 667 | 33 | |||||||
Interest/NOPBT | |||||||||